Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Condition:   Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Interventions:   Drug: Nipocalimab;   Drug: Placebo Sponsor:   Janssen Research & Development, LLC Not yet recruiting

Source: ClinicalTrials.gov - April 14, 2022 Category: Research Source Type: clinical trials